{"id":{"repo_id":"catania","oai_identifier":"oai:www.iris.unict.it:20.500.11769/583117"},"canonical_url":"https://search.dev.ndltd.org/etd/catania/oai:www.iris.unict.it:20.500.11769/583117","repository":{"repo_id":"catania","name":"Università degli Studi di Catania","base_url":"https://www.iris.unict.it/oai/request"},"display":{"title":"Evidence for enhanced oxidative stress in smokers with severe asthma","abstract":"Background As part of the U-BIOPRED project, extensive clinical and biomarker information was collected from cohorts of adult severe asthma smokers/ex-smokers (SAs/ex) and severe asthmatic non-smokers (SAn). Oxidative stress in SAs/ex vs SAn patients was investigated by analysing urinary 8-iso-PGF2a and the mRNA expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways, in relation to clinical outcomes. Methods Urine and induced sputum (IS) were obtained from severe asthma patients. A bronchoscopy to obtain bronchial biopsy (BB) and brushing (BBr) was performed in a subset of patients. Urinary 8-iso-PGF2a was quantified using mass spectrometry. IS, BB and BBr were processed for mRNA expression microarray analysis. Results Urinary 8-iso-PGF2a was increased in SAs/ex compared to SAn (p< 0.001) and in current smokers vs ex-smokers and non-smokers (p= 0.004). Sputum mRNA expression of NOX2 were increased in SAs/ex compared to SAn (three probe-sets with p< 0.05). The mRNA expression of antioxidant enzymes was similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in BBr of SAs/ex compared to SAn (p= 0.029). NOS2 mRNA expression in BBr correlated with FeNO (p< 0.001). FeNO was lower in current-smokers than in ex-smokers (p= 0.007) indicating an effect of active smoking. Conclusions The data suggests evidence of greater systemic oxidative stress in SAs/ex with significant effects on the mRNA expression of NOX2 and NOS2 in the airways of severe asthmatic patients.","abstract_html":"Background As part of the U-BIOPRED project, extensive clinical and biomarker information was collected from cohorts of adult severe asthma smokers/ex-smokers (SAs/ex) and severe asthmatic non-smokers (SAn). Oxidative stress in SAs/ex vs SAn patients was investigated by analysing urinary 8-iso-PGF2a and the mRNA expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways, in relation to clinical outcomes. Methods Urine and induced sputum (IS) were obtained from severe asthma patients. A bronchoscopy to obtain bronchial biopsy (BB) and brushing (BBr) was performed in a subset of patients. Urinary 8-iso-PGF2a was quantified using mass spectrometry. IS, BB and BBr were processed for mRNA expression microarray analysis. Results Urinary 8-iso-PGF2a was increased in SAs/ex compared to SAn (p< 0.001) and in current smokers vs ex-smokers and non-smokers (p= 0.004). Sputum mRNA expression of NOX2 were increased in SAs/ex compared to SAn (three probe-sets with p< 0.05). The mRNA expression of antioxidant enzymes was similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in BBr of SAs/ex compared to SAn (p= 0.029). NOS2 mRNA expression in BBr correlated with FeNO (p< 0.001). FeNO was lower in current-smokers than in ex-smokers (p= 0.007) indicating an effect of active smoking. Conclusions The data suggests evidence of greater systemic oxidative stress in SAs/ex with significant effects on the mRNA expression of NOX2 and NOS2 in the airways of severe asthmatic patients.","abstract_has_math":false,"creators":["EMMA, ROSALIA"],"institution":"Università degli studi di Catania","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["POLOSA, Riccardo","MALATINO, Lorenzo"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-11-21","date_published":"2017-11-21","updated_at":"2026-07-24T01:35:10Z","subjects":["Severe asthma, tobacco smoke, oxidative stress, oxidants, antioxidants, FeNO"],"languages":["eng"],"rights":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/20.500.11769/583117","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Emma, Rosalia","POLOSA, Riccardo","MALATINO, Lorenzo"]},{"key":"dc:creator","label":"Author","values":["EMMA, ROSALIA"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-11-21"]},{"key":"dc:publisher","label":"Institution","values":["Università degli studi di Catania","place:Catania"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Severe asthma, tobacco smoke, oxidative stress, oxidants, antioxidants, FeNO"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/20.500.11769/583117"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Background As part of the U-BIOPRED project, extensive clinical and biomarker information was collected from cohorts of adult severe asthma smokers/ex-smokers (SAs/ex) and severe asthmatic non-smokers (SAn). Oxidative stress in SAs/ex vs SAn patients was investigated by analysing urinary 8-iso-PGF2a and the mRNA expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways, in relation to clinical outcomes. Methods Urine and induced sputum (IS) were obtained from severe asthma patients. A bronchoscopy to obtain bronchial biopsy (BB) and brushing (BBr) was performed in a subset of patients. Urinary 8-iso-PGF2a was quantified using mass spectrometry. IS, BB and BBr were processed for mRNA expression microarray analysis. Results Urinary 8-iso-PGF2a was increased in SAs/ex compared to SAn (p< 0.001) and in current smokers vs ex-smokers and non-smokers (p= 0.004). Sputum mRNA expression of NOX2 were increased in SAs/ex compared to SAn (three probe-sets with p< 0.05). The mRNA expression of antioxidant enzymes was similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in BBr of SAs/ex compared to SAn (p= 0.029). NOS2 mRNA expression in BBr correlated with FeNO (p< 0.001). FeNO was lower in current-smokers than in ex-smokers (p= 0.007) indicating an effect of active smoking. Conclusions The data suggests evidence of greater systemic oxidative stress in SAs/ex with significant effects on the mRNA expression of NOX2 and NOS2 in the airways of severe asthmatic patients."]},{"key":"dc:title","label":"Title","values":["Evidence for enhanced oxidative stress in smokers with severe asthma"]}]}],"canonical_facts":{"dc:contributor":["Emma, Rosalia","POLOSA, Riccardo","MALATINO, Lorenzo"],"dc:creator":["EMMA, ROSALIA"],"dc:date":["2017-11-21"],"dc:description":["Background As part of the U-BIOPRED project, extensive clinical and biomarker information was collected from cohorts of adult severe asthma smokers/ex-smokers (SAs/ex) and severe asthmatic non-smokers (SAn). Oxidative stress in SAs/ex vs SAn patients was investigated by analysing urinary 8-iso-PGF2a and the mRNA expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways, in relation to clinical outcomes. Methods Urine and induced sputum (IS) were obtained from severe asthma patients. A bronchoscopy to obtain bronchial biopsy (BB) and brushing (BBr) was performed in a subset of patients. Urinary 8-iso-PGF2a was quantified using mass spectrometry. IS, BB and BBr were processed for mRNA expression microarray analysis. Results Urinary 8-iso-PGF2a was increased in SAs/ex compared to SAn (p< 0.001) and in current smokers vs ex-smokers and non-smokers (p= 0.004). Sputum mRNA expression of NOX2 were increased in SAs/ex compared to SAn (three probe-sets with p< 0.05). The mRNA expression of antioxidant enzymes was similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in BBr of SAs/ex compared to SAn (p= 0.029). NOS2 mRNA expression in BBr correlated with FeNO (p< 0.001). FeNO was lower in current-smokers than in ex-smokers (p= 0.007) indicating an effect of active smoking. Conclusions The data suggests evidence of greater systemic oxidative stress in SAs/ex with significant effects on the mRNA expression of NOX2 and NOS2 in the airways of severe asthmatic patients."],"dc:identifier":["https://hdl.handle.net/20.500.11769/583117"],"dc:language":["eng"],"dc:publisher":["Università degli studi di Catania","place:Catania"],"dc:rights":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"],"dc:subject":["Severe asthma, tobacco smoke, oxidative stress, oxidants, antioxidants, FeNO"],"dc:title":["Evidence for enhanced oxidative stress in smokers with severe asthma"],"dc:type":["info:eu-repo/semantics/doctoralThesis"]},"updated_at":"2026-07-24T01:35:10Z"}